Therefore, we generated four independent cohorts that covered the most common microarray platforms, ultimately elucidating the comprehensive landscape of CXCL10 in ovarian cancer clinical outcomes, TME characteristics, and underlying mechanisms. The gene discussed is CXCL10; the disease is ovarian carcinoma.